These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15219266)

  • 21. Effect of reproterol either alone or combined with disodium cromoglycate on airway responsiveness to methacholine.
    Kanniess F; Jörres RA; Magnussen H
    Pulm Pharmacol Ther; 2005; 18(5):315-20. PubMed ID: 15939309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of selective and non-selective phosphodiesterase inhibitors on allergen- and leukotriene C(4)-induced contractions in passively sensitized human airways.
    Schmidt DT; Watson N; Dent G; Rühlmann E; Branscheid D; Magnussen H; Rabe KF
    Br J Pharmacol; 2000 Dec; 131(8):1607-18. PubMed ID: 11139438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of cell-free brain cyclic nucleotide phosphodiesterase activities to cyclic AMP decay in intact brain slices.
    Whalin ME; Garrett RL; Thompson WJ; Strada SJ
    Second Messengers Phosphoproteins; 1988-1989; 12(5-6):311-25. PubMed ID: 2856115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of human cardiac cyclic AMP-phosphodiesterases by R 80122, a new selective cyclic AMP-phosphodiesterase III inhibitor: a comparison with other cardiotonic compounds.
    de Cheffoy de Courcelles D; de Loore K; Freyne E; Janssen PA
    J Pharmacol Exp Ther; 1992 Oct; 263(1):6-14. PubMed ID: 1328613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphodiesterase (PDE) 7 in inflammatory cells from patients with asthma and COPD.
    Jones NA; Leport M; Holand T; Vos T; Morgan M; Fink M; Pruniaux MP; Berthelier C; O'Connor BJ; Bertrand C; Page CP
    Pulm Pharmacol Ther; 2007; 20(1):60-8. PubMed ID: 16427796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
    Torphy TJ; Cieslinski LB
    Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Superoxide radical scavenging by phenolic bronchodilators under aprotic and aqueous conditions.
    Zwicker K; Damerau W; Dikalov S; Scholtyssek H; Schimke I; Zimmer G
    Biochem Pharmacol; 1998 Aug; 56(3):301-5. PubMed ID: 9744566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reproterol and the muscle of the trachea and bronchi: in vitro and in vivo comparative studies with various drugs used in the treatment of asthma.
    Di Mezza F; Giordano L; Scognamiglio M; Montanaro A; Marmo E
    Respiration; 1981; 42(3):175-83. PubMed ID: 7313343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclic AMP compartmentation due to increased cAMP-phosphodiesterase activity in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8).
    Georget M; Mateo P; Vandecasteele G; Lipskaia L; Defer N; Hanoune J; Hoerter J; Lugnier C; Fischmeister R
    FASEB J; 2003 Aug; 17(11):1380-91. PubMed ID: 12890691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of Paeonia lactiflora roots extract on cAMP-phosphodiesterase activity and related anti-inflammatory action.
    Jiang D; Chen Y; Hou X; Xu J; Mu X; Chen W
    J Ethnopharmacol; 2011 Sep; 137(1):914-20. PubMed ID: 21782011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4.
    Blease K; Burke-Gaffney A; Hellewell PG
    Br J Pharmacol; 1998 May; 124(1):229-37. PubMed ID: 9630364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of eotaxin formation and eosinophil migration by selective inhibitors of phosphodiesterase type 4 isoenzyme.
    Silva PM; Alves AC; Serra MF; Pires AL; Silva JP; Barreto EO; Cordeiro RS; Jose PJ; Teixeira MM; Lagente V; Martins MA
    Br J Pharmacol; 2001 Sep; 134(2):283-94. PubMed ID: 11564646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma membrane-bound cyclic AMP phosphodiesterase activity in 3T3-L1 adipocytes.
    Zhang X; Carey GB
    Comp Biochem Physiol B Biochem Mol Biol; 2004 Mar; 137(3):309-16. PubMed ID: 15050518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type 4 inhibitor.
    Collado MC; Beleta J; Martinez E; Miralpeix M; Domènech T; Palacios JM; Hernández J
    Br J Pharmacol; 1998 Mar; 123(6):1047-54. PubMed ID: 9559885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
    Kelly JJ; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of CHO-K1 cells stably expressing PDE-IV enzymes. Whole-cell cAMP determinations vs broken-cell enzymatic assays.
    Pon DJ; Plant M; Tkach J; Boulet L; Muise E; Allen RA; Rodger IW
    Cell Biochem Biophys; 1998; 29(1-2):159-78. PubMed ID: 9631244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
    Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
    Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.
    Verghese MW; McConnell RT; Strickland AB; Gooding RC; Stimpson SA; Yarnall DP; Taylor JD; Furdon PJ
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1313-20. PubMed ID: 7891349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pregnancy induces a modulation of the cAMP phosphodiesterase 4-conformers ratio in human myometrium: consequences for the utero-relaxant effect of PDE4-selective inhibitors.
    Méhats C; Tanguy G; Paris B; Robert B; Pernin N; Ferré F; Leroy MJ
    J Pharmacol Exp Ther; 2000 Feb; 292(2):817-23. PubMed ID: 10640323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of theophylline on lymphocyte phosphodiesterase activity.
    Tohda Y; Nakahara H; Kubo H; Ohkawa K; Fukuoka M; Nakajima S
    Gen Pharmacol; 1998 Sep; 31(3):409-13. PubMed ID: 9703210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.